PRKAA1 and polycystic ovary syndrome: Previous studies have linked metformin treatment of PCOS with changes in gut microbiota, suggesting that AMPK activation may influence goblet cell secretion of antimicrobial peptides, thereby affecting gut microbiota homeostasis.